US9447444B2ActiveUtilityA1
Biosynthesis of opiate alkaloids
Assignee: SUN PHARMACEUTICAL IND (AUSTRALIA) PTY LTDPriority: Mar 13, 2012Filed: Mar 12, 2013Granted: Sep 20, 2016
Est. expiryMar 13, 2032(~5.7 yrs left)· nominal 20-yr term from priority
C12N 15/52C12Y 114/21001C12Y 201/01117C12N 9/0006C12N 9/0071C12P 17/188C12Y 114/21002C12N 9/1007C12N 9/18C12Y 206/01052C12P 17/18C07K 14/415C12N 15/8243
93
PatentIndex Score
20
Cited by
85
References
6
Claims
Abstract
The disclosure relates to a nucleic acid molecule isolated from a Papaver somniferum cultivar that produces the opiate alkaloid noscapine which comprises 10 genes involved in the biosynthesis of opiate alkaloids.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1. A method to produce a P. somniferum plant that has altered expression of a polypeptide, comprising:
i) mutagenizing a wild-type seed from a wild-type P. somniferum plant that expresses said polypeptide, thereby generating mutagenized seed;
ii) cultivating the mutagenized seed to produce first and subsequent generations of mutagenized plants;
iii) obtaining seed from the first and subsequent generations of mutagenized plants;
iv) determining if the plants from the seed from said first and subsequent generations of mutagenized plants have an altered nucleotide sequence, altered expression of said polypeptide or both, an altered nucleotide sequence and altered expression of said polypeptide by obtaining a nucleic acid sample from the plant of said first or subsequent generation of mutagenized plants and analysing the nucleic acid sample for presence of a nucleic acid molecule comprising a nucleotide sequence having at least 90% sequence identity to the sequence of SEQ ID NO: 7, 8, 9 or 10 and that encodes a polypeptide with opiate alkaloid biosynthetic activity; and optionally
v) comparing the nucleotide sequence of the nucleic acid molecule in said sample to a nucleotide sequence of a nucleic acid molecule of the wild-type plant.
2. The method according to claim 1 wherein said nucleic acid sample obtained from the mutagenized seed or plant is analysed by a method comprising:
i) extracting nucleic acid molecules from said first and subsequent generations of mutagenized plants;
ii) amplifying a part of said extracted nucleic acid molecules by a polymerase chain reaction, thereby generating amplified nucleic acid comprising a part of a nucleic acid molecule comprising a nucleotide sequence having at least 90% sequence identity to the sequence of SEQ ID NO: 7, 8, 9 or 10;
iii) forming a preparation comprising the amplified nucleic acid and nucleic acid extracted from wild-type plants to form heteroduplex nucleic acid;
iv) incubating said preparation with a single stranded nuclease that cuts at a region of heteroduplex nucleic acid to identify a mismatch in said heteroduplex; and
v) determining the site of the mismatch in said nucleic acid heteroduplex.
3. The method according to claim 1 , wherein said P. somniferum plant has enhanced opiate alkaloid biosynthetic activity.
4. The method according to claim 1 , wherein said P. somniferum plant has reduced or abrogated opiate alkaloid biosynthetic activity.
5. A P. somniferum plant obtained by the method of claim 1 .
6. The method of claim 1 , wherein the nucleic acid sample is analysed for the presence of a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO: 7, 8, 9 or 10.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.